8 March 2021 in Proceedings of the National Academy of Sciences
Significance: Caveolin-1 (CAV1) loss-of-function mutations are a hereditary cause of pulmonary arterial hypertension (PAH), but wild-type CAV1 is also decreased in the vascular lesions of idiopathic and disease-associated PAH. Using human pulmonary artery endothelium, lung tissue, and serum from Cav1
−/−
mice, as well as fibroblasts and serum from patients with CAV1 mutations, CAV1 deficiency produced a dysfunctional, PAH-like endothelial phenotype driven by an interferon-biased inflammatory response with constitutive STAT and AKT activation. Inhibiting JAK/STAT and PI3K/AKT reversed the aberrant endothelial phenotype of CAV1 loss and may similarly ameliorate pathologic vascular remodeling in PAH. Exogenous interferon alone reduced CAV1 expression and activated these same signaling pathways, suggesting that CAV1 insufficiency may contribute to the development of autoimmune and autoinflammatory disease-associated PAH.
2 June 2018 in The Journal of Infectious Diseases
The major surface glycoprotein (Msg) is the most abundant surface protein among Pneumocystis species. Given that Msg is present on both the cyst and trophic forms of Pneumocystis and that dendritic cells play a critical role in initiating host immune responses, we undertook studies to examine activation of bone marrow–derived myeloid dendritic cells by Msg purified from Pneumocystis murina. Incubation of dendritic cells with Msg did not lead to increased expression of CD40, CD80, CD86, or major histocompatibility complex class II or to increased secretion of any of 10 cytokines. Microarray analysis identified very few differentially expressed genes. In contrast, lipopolysaccharide-activated dendritic cells had positive results of all of these assays. However, Msg did bind to mouse mannose macrophage receptor and human DC-SIGN, 2 C-type lectins expressed by dendritic cells that are important in recognition of pathogen-associated high-mannose glycoproteins. Deglycosylation of Msg demonstrated that this binding was dependent on glycosylation. These studies suggest that Pneumocystis has developed a mechanism to avoid activation of dendritic cells, potentially by the previously identified loss of genes that are responsible for the high level of protein mannosylation found in other fungi.
1 October 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
MSMohammad A. H. Siddique
+7
HIF activation alone does not conclusively lead to human PH, suggesting that HIF-independent signaling may also contribute to hypoxia-induced PH. This study demonstrated that PHD2 silencing-induced pseudohypoxia in human lung endothelial cells suppresses apoptosis and activates STAT, effects that persist despite HIF2α inhibition or knockdown and are attributed to AKT and ERK activation, JNK inhibition, and AIP1 loss. These findings align with observations in lung endothelial cells and tissues from PAH rodent models and patients.
19 November 2010 in Blood
Abstract 1018 Th17 cells are thought to be meta-stable, short-lived end-effector T lymphocytes and purportedly have a limited ability to form memory. Paradoxically, we have recently reported that tumor-specific Th17-polarized CD4+ T cells eradicate established tumor more efficiently than their Th1 counterparts did. Mounting evidence suggests that the advanced differentiation stage of the effectors impairs their self-renewal ability and negatively correlates with the anti-tumor functionality of T cells upon adoptive transfer. We hypothesized that in vivo advantage of Th17-polarized cells over Th1 cells might result from more naïve, less senescent properties preserved during the initial in vitro programming. Using a TCR gene engineered Th17 cells we showed that IL-17A or CCR6 signaling contributed only modestly to tumor rejection, and that Th17-polarized cells had to activate type 1 defining transcription factor tbx21 (t-bet) and secrete IFN-γ in vivo, underscoring the less mature, dualistic nature of type 17 responses. Although we confirmed that Th17-polarized cells acquired an end-effector-like phenotype (CD27low/CD62Llow), we found that they also exhibited lower levels of inhibitory receptors and multiple markers of T cell terminal differentiation. While previous work used IL-17 to trace the fate of Th17 cells, in a congenic system we observed that most type 17 cells lost the capacity to produce IL-17A during in vivo expansion, although they efficiently persisted and formed memory. Serial global gene expression profiling demonstrated the loss of IL-17A expression and the acquisition of a phenotype with Th1-like features, nevertheless the molecular signature of Th17-derived cells remained significantly distinct from that of Th1-derived memory cells. Using gene set enrichment analysis (GSEA) we observed a highly significant non-random distribution of genes associated with less mature memory T cell subset in Th17-derived population. Ex vivo recovered Th17-derived memory cells expressed high levels of genes related to improved survival, functionality and self-renewal, including wnt/β-catenin target tcf-7, thus closely resembling the pattern previously described by us in a self-renewing memory stem-like CD8+ subset generated pharmacologically. We confirmed the activity of this stem-related pathway during the initial Th17 polarization, as evidenced by the striking accumulation of β-catenin and progressive induction of tcf-7 to a level above one found in naïve cells. In summary, we report that Th17-derived cells expressed more “stem-like” characteristics distinct from Th1-derived effectors as evidenced by their molecular signature and dramatically enhanced ability to survive in vivo and reject tumor. This suggests that Th17-polarizing conditions trigger a distinctive developmental program that dissociates proliferation from maturation.